Literature DB >> 23494865

Pyloric stenosis associated Crohn's disease responding to adalimumab therapy.

Sameer Gaggar1, John Scott, Nicholas Thompson.   

Abstract

Gastroduodenal Crohn's disease (CD) is rare and the response to standard medical therapy is often poor. Anti-tumor necrosis factor therapy has revolutionised the treatment of CD. We present a patient with pyloric stenosis associated with CD which improved with Adalimumab therapy. We recommend considering anti-tumor necrosis factor therapy in symptomatic gastroduodenal CD.

Entities:  

Keywords:  Adalimumab; Anti-tumor necrosis factor therapy; Crohn’s disease; Pyloric stenosis

Year:  2012        PMID： 23494865      PMCID： PMC3596519          DOI： 10.4292/wjgpt.v3.i6.97

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN： 2150-5349


  16 in total

Review 1.  Gastroduodenal Crohn's disease: medical management.

Authors:  William J Tremaine
Journal:  Inflamm Bowel Dis       Date:  2003-03       Impact factor: 5.325

2.  Successful infliximab therapy for a duodenal stricture caused by Crohn's disease.

Authors:  Albert B Knapp; Felice J Mirsky; Evan H Dillon; Burton I Korelitz
Journal:  Inflamm Bowel Dis       Date:  2005-12       Impact factor: 5.325

3.  Role of strictureplasty in surgical treatment of Crohn's disease.

Authors:  Kitaro Futami; Sumitaka Arima
Journal:  J Gastroenterol       Date:  2005-03       Impact factor: 7.527

4.  Repeated hydrostatic balloon dilation in obstructive gastroduodenal Crohn's disease.

Authors:  U K Murthy
Journal:  Gastrointest Endosc       Date:  1991 Jul-Aug       Impact factor: 9.427

5.  Duodenal Crohn's disease successfully treated with adalimumab.

Authors:  A Tursi
Journal:  Endoscopy       Date:  2011-01-26       Impact factor: 10.093

6.  Long-term results of surgical treatment for Crohn's disease of the duodenum.

Authors:  T M Ross; V W Fazio; R G Farmer
Journal:  Ann Surg       Date:  1983-04       Impact factor: 12.969

Review 7.  Thyroid function tests: a review.

Authors:  G Shivaraj; B Desai Prakash; V Sonal; K Shruthi; H Vinayak; M Avinash
Journal:  Eur Rev Med Pharmacol Sci       Date:  2009 Sep-Oct       Impact factor: 3.507

8.  Long-term outcome of endoscopic balloon dilation in obstructive gastroduodenal Crohn's disease.

Authors:  T Matsui; S Hatakeyama; K Ikeda; T Yao; K Takenaka; T Sakurai
Journal:  Endoscopy       Date:  1997-09       Impact factor: 10.093

9.  Successful treatment of refractory duodenal Crohn's disease with infliximab.

Authors:  Masaru Odashima; Michiro Otaka; Mario Jin; Youhei Horikawa; Tamostu Matsuhashi; Reina Ohba; Shigeto Koizumi; Nobukatsu Kinoshita; Taiji Takahashi; Sumio Watanabe
Journal:  Dig Dis Sci       Date:  2006-12-14       Impact factor: 3.487

10.  Treatment of isolated gastric Crohn's disease with inhaled corticosteroids.

Authors:  Samar H Ibrahim; Thomas C Smyrk; William A Faubion
Journal:  Case Rep Gastroenterol       Date:  2008-11-05
View more
  2 in total

1.  Pyloric Stenosis: A Rare Manifestation of Crohn's Disease.

Authors:  Rajarajeshwari Ramachandran; Eric Then; Tyler Grantham; Swetha Parvataneni; Vinaya Gaduputi
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-01-31

2.  Pyloric stenosis as a manifestation of isolated gastric Crohn's disease responding to intralesional steroid injection and balloon dilation: a case report.

Authors:  K Balendran; S Udumalagala; N M M Nawaraththne
Journal:  J Med Case Rep       Date:  2019-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.